BioSante Site 036

Ridgefield, Connecticut 06877

0 studies enrolling now · 3 studies all time

What they study most

Hypoactive Sexual Desire Disorder

Studies at this site

• Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women — Completed
• Safety and Efficacy of LibiGel® for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women — Completed
• Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) — Completed